Diabetes Mellitus and Ischemic Heart Disease, Role of Glycosilated Hemoglobin

Abstract

One of the serious complications of diabetes mellitus (DM) is macrovascular, based on atherosclerotic vascular lesions. According to literature, patients with diabetes are exposed to two to fourfold increase in the risk of developing cardiovascular disease compared with non-diabetic patients. Many authors indicate that in patients with diabetes, the incidence of latent, asymptomatic myocardial ischemia increases. Acute coronary syndrome can be manifested by autonomic dysfunction - nausea, sweating, dizziness - in the absence of a painful cardiac component that can lead the doctor away from the correct diagnosis. Between diabetes mellitus and ischemic heart disease, equal sign can be put. Thorough control of glycosylated hemoglobin level allows reducing the incidence of microvascular complications, which ultimately leads to a reduction in lethal macrovascular complications.